Skip to main content
Hit enter to search or ESC to close
Translation of an allogenic tissue engineering product with mesenchymal stromal cells from Wharton’s jelly for the treatment of osteonecrosis in paediatric oncology patients
© 2022 VHIR Annual Report 2021.
Six Top Stories
Facts & Figures
Partners and Acknowledgements
VHIR Annual Report 2021